Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer - long-term follow-up of the SPCG-6 study.

Frederik B Thomsen, Klaus Brasso, Ib J Christensen, Jan-Erik Johansson, Anders Angelsen, Teuvo L J Tammela, Peter Iversen, Scandinavian Prostate Cancer Group

    17 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer - long-term follow-up of the SPCG-6 study.'. Together they form a unique fingerprint.

    Medicine & Life Sciences